RxDoctor Payments Data

Emily Webb

Family · Lafayette, GANPI 1669721007

Payments from drug & device makers

$788in general payments, 2019–2025

Across 43 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$139
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$126
  • Xeris Pharmaceuticals, Inc.$84
  • Novo Nordisk$74
  • Exact Sciences$66
  • AstraZeneca$55
  • plus $243 from 10 others

What the payments were for

  • Food & beverage$788100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$788 in reported general payments places this provider in the 60th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$19,030
Medicare patients
133
Services billed
694

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide74$118,826
EliquisApixaban57$76,024
JardianceEmpagliflozin48$67,662
JanuviaSitagliptin Phosphate37$53,008
TrulicityDulaglutide30$49,271
MyrbetriqMirabegron23$24,136
TradjentaLinagliptin16$21,802
VascepaIcosapent Ethyl11$11,438
Breo ElliptaFluticasone/Vilanterol14$9,114
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$6,739
Albuterol Sulfate HfaAlbuterol Sulfate77$3,316
Lidocaine37$3,234
Rosuvastatin Calcium333$3,024
Levothyroxine Sodium349$2,631
Gabapentin192$2,326

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$74$118,82674 claims
PfizerEliquis$32$76,02457 claims
Lilly USA, LLCTrulicity$43$49,27130 claims
AbbVieSynthroid$139$1,28939 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,258 family providers in Georgia.

Other family in Lafayette

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →